Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flexible hazard regression modeling for medical cost data.

Arvind K Jain1, Robert L Strawderman

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109-2029, USA. arvindj@umich.edu

Biostatistics (Oxford, England)
|August 23, 2003
PubMed
Summary

This study introduces a new statistical method to accurately model lifetime medical costs, even with informative censoring. The approach effectively incorporates patient covariates for better cost prediction in healthcare economics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causal mediation analysis: selection with asymptotically valid inference.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2025
Same author

On the role of Volterra integral equations in self-consistent, product-limit, inverse probability of censoring weighted, and redistribution-to-the-right estimators for the survival function.

Lifetime data analysis·2024
Same author

Insertable cardiac monitor-guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM-REDUCE-AF trial).

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2023
Same author

Discussion on "Instrumental variable estimation of the causal hazard ratio," by Linbo Wang, Eric Tchetgen Tchetgen, Torben Martinussen, and Stijn Vansteelandt.

Biometrics·2022
Same author

Metal-Organic Precursor Synthesis, Structural Characterization, and Multiferroic Properties of GdFeO<sub>3</sub> Nanoparticles.

ACS omega·2022
Same author

Affordability of Forensic Assertive Community Treatment Programs: A Return-on-Investment Analysis.

Psychiatric services (Washington, D.C.)·2022

Area of Science:

  • Biostatistics
  • Health Economics
  • Medical Cost Analysis

Background:

  • Modeling cumulative medical costs with censored follow-up is challenging due to informative censoring, which invalidates standard survival analysis.
  • Existing nonparametric methods often struggle to incorporate covariate information effectively.
  • Accurate cost modeling is crucial for healthcare resource allocation and patient outcome assessment.

Purpose of the Study:

  • To propose a novel statistical methodology for modeling lifetime medical costs in the presence of informative censoring.
  • To develop a flexible approach that incorporates covariate information and covariate-by-cost interactions without restrictive parametric assumptions.
  • To address the limitations of current methods in handling complex cost data and censoring mechanisms.

Main Methods:

Related Experiment Videos

  • Adaptation of the HARE (Hazard Rate Regression Estimation) methodology for modeling the hazard function of lifetime cost endpoints.
  • Utilizing linear splines and their tensor products for adaptive model building, allowing for complex covariate effects.
  • Employing inverse probability of censoring weighted estimating equations to handle the issue of informative censoring.

Main Results:

  • The proposed method successfully models lifetime medical costs by adapting the HARE methodology.
  • The use of linear splines and tensor products allows for flexible incorporation of covariates and their interactions.
  • Inverse probability of censoring weighting effectively addresses informative censoring in cost data analysis.

Conclusions:

  • The developed statistical approach provides a robust framework for analyzing censored medical cost data.
  • This method enhances the ability to model healthcare costs by accommodating informative censoring and complex covariate relationships.
  • The approach is validated through simulation studies and demonstrated on end-stage renal disease dialysis cost data.